Recombinant HIV2 gp36 protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The HIV2 gp36 protein also known as the gp-36 protein or simply gp36 plays a vital role in the viral entry process of HIV-2. With an approximate molecular mass of 36 kDa gp36 is a transmembrane glycoprotein expressed primarily on the surface of the HIV-2 virus. It facilitates the fusion of the viral membrane with the host cell allowing the virus to inject its genetic material into the host. The protein forms part of the envelope glycoprotein complex and is necessary for the structural integrity and infectivity of the virus.

Biological function summary

Gp36 of HIV impacts virus-host interactions by mediating the fusion between the viral envelope and the target cell membrane. This protein forms part of the envelope glycoprotein complex which includes other proteins such as gp105. Through interactions with cellular receptors gp36 aids in the initial stages of infection by enabling viral entry into host cells. This interaction characterizes its important function in the pathogenesis and life cycle of HIV-2.

Pathways

The gp 36 HIV protein is indispensable in the viral entry pathway of HIV-2. This pathway involves binding to CD4 receptors and coreceptors such as CCR5 or CXCR4 on the surface of host cells enabling the fusion process to occur. By associating with gp41 a homologous protein in HIV-1 gp36 is pivotal in facilitating this binding and fusion mechanism necessary for successful infection. The interaction between gp36 and these receptors signifies its integration and operation within a critical biological process required for viral entry.

Gp36 HIV is intrinsically linked to the development of HIV-2 infection a less widespread but no less significant cause of AIDS than HIV-1. This protein's function relates directly to the virus's ability to infect human hosts and sustain its presence which contributes to immune system failure. Moreover its association with gp41-like proteins highlights its importance in the therapeutic targeting of HIV-2. Focusing on gp36 as a biochemical target helps in developing treatments and vaccines aimed at reducing the infectivity and transmission of HIV-2.